News

Our latest news releases

Olswang CR Report 2016/17: Creating connections that make an impact

Olswang CR Report 2016/17: Creating connections that make an impact

International law firm Olswang's unique approach to CR achieves tangible results because it understands the power of connections. The firm's CR work builds effective relationships and connections with its people, its clients and the communities it works in to create real positive change. Olswang's new 2016/17 CR report, 'Creating connections', explains the impact the firm makes through the variety of programmes that it is involved in across its international network to actively manage its social and environmental impact...

18 April 2016

Olswang advises on Series A financing round of EUR 14 m for Topas Therapeutics GmbH

International law firm Olswang has advised existing client Epidarex Capital as lead investor in the Series A financing round of Topas Therapeutics GmbH (“Topas”). Topas is the first spin out from Evotec AG and aims to build a unique pipeline of clinical-stage development projects to treat autoimmune diseases. 

29 March 2016

prev set

prev

next

next set